Treg-mediated immune control appears to be compromised in people with AD (Faridar et al., 2020). In preclinical studies, Tregs that were transferred into AD mice entered the brain and stopped Aβ ...

Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donor-derived human leukocyte antigen (HLA) is a promising strategy to induce immune tolerance to ...

Coya’s therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. For more information about Coya, please visit www.coyatherapeutics.com ...

STEMCELL Technologies launched the EasySep™ Release Mouse CD4+ CD304+ Regulatory T-Cell Isolation Kit that targets the CD304 surface marker and does not interfere with IL-2 signaling.

By testing a clinically approved drug on human Treg cells, the researchers found they died more readily than normal T cells. This discovery identified a "therapeutic window" where Treg cells could ...